You have 9 free searches left this month | for more free features.

Formyltetrahydrofolates

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting
  • Advanced Esophageal Adenocarcinoma
  • +14 more
  • (no location specified)
Jan 3, 2023

Gastric Cancer Trial in Australia, New Zealand (drug, radiation, procedure)

Active, not recruiting
  • Gastric Cancer
  • Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
  • +2 more
  • Newcastle, New South Wales, Australia
  • +22 more
Mar 21, 2022

Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil

Recruiting
  • Colon Cancer
  • +4 more
  • 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 15, 2022

Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond

Completed
  • Mucinous Adenocarcinoma of the Rectum
  • +9 more
  • intensity-modulated radiation therapy
  • +4 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Jul 19, 2021

Colorectal Adenocarcinoma, RAS Wild Type, Stage III Colorectal Cancer AJCC v7 Trial in Los Angeles (biological, drug, other)

Terminated
  • Colorectal Adenocarcinoma
  • +8 more
  • Panitumumab
  • +6 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jun 8, 2020

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,

Completed
  • Pancreatic Adenocarcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020

Cancer of Rectum, Cancer of the Rectum, Tumor, Rectum Trial in Saint Louis (Radiation, Oxaliplatin, Leucovorin)

Completed
  • Cancer of Rectum
  • +6 more
  • Radiation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 10, 2021

Stomach Tumors, Esophageal Tumors Trial in Saint Louis (Irinotecan, Trastuzumab, Oxaliplatin)

Completed
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 12, 2020

Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Boston

Completed
  • Rectal Mucinous Adenocarcinoma
  • +10 more
  • Radiotherapy
  • +4 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Dec 3, 2018

Colorectal Cancer Trial in United States (bevacizumab, fluorouracil, irinotecan HCl)

Completed
  • Colorectal Cancer
  • bevacizumab
  • +4 more
  • Greenbrae, California
  • +109 more
Jul 23, 2018

Colorectal Cancer Trial in Maywood (fluorouracil, leucovorin calcium)

Terminated
  • Colorectal Cancer
  • Maywood, Illinois
    Loyola University Medical Center
Jul 19, 2016

Stomach Tumors, Esophageal Tumors Trial in United States (5-fluorouracil, Oxaliplatin, Leucovorin)

Completed
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Birmingham, Alabama
  • +3 more
Dec 8, 2015

Gastric Cancer Trial in Changchun (S-1, leucovorin, oxaliplatin)

Unknown status
  • Gastric Cancer
  • S-1, leucovorin, oxaliplatin
  • Changchun, Jilin, China
    Jilin Provincial Tumor Hospital
Mar 4, 2015

Gastric Cancer Trial in United States (drug, procedure, radiation)

Completed
  • Gastric Cancer
  • Denver, Colorado
  • +29 more
Jun 22, 2015

Carcinoma, Liver Diseases, Hepatocellular Carcinoma Trial in Shanghai (S-1 combined with Leucovorin)

Unknown status
  • Carcinoma
  • +2 more
  • S-1 combined with Leucovorin
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital
Feb 14, 2012

Mild Hyperhomocysteinemia Trial in Nijmegen (5-formyltetrahydrofolate (10 mg/ml) (Pharmachemie bv))

Completed
  • Mild Hyperhomocysteinemia
  • 5-formyltetrahydrofolate (10 mg/ml) (Pharmachemie bv)
  • Nijmegen, Netherlands
    Radboud University Medical center Nijmegen
May 5, 2009